Anti-VEGF therapy in breast and lung mouse models of cancers

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Marina, Di Domenico ^a   Carmela, Ricciardi ^a   Alfredo, Fusco ^b   Giovanna Maria, Pierantoni ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; BREAST CANCER; CANCER MODEL; CANCER THERAPY; CELL INFILTRATION; HUMAN; LUNG CANCER; MACROPHAGE; METASTASIS; NONHUMAN; REVIEW; TISSUE INJURY; TUMOR GROWTH; VASCULARIZATION; WOUND HEALING;

MURINAE;

EID: 78650745238     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/947928     Document Type: Review

References (25)

1. Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine 1995 1 1 27 31
2. Pradeep C. R., Sunila E. S., Kuttan G., Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies Integrative Cancer Therapies 2005 4 4 315 321
3. Dvorak H. F., Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy Journal of Clinical Oncology 2002 20 21 4368 4380
4. Roskoski R. Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression Critical Reviews in Oncology/Hematology 2007 62 3 179 213
5. Konecny G. E., Meng Y. G., Untch M., Wang H.-J., Bauerfeind I., Epstein M., Stieber P., Vernes J.-M., Gutierrez J., Hong K., Beryt M., Hepp H., Slamon D. J., Pegram M. D., Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients Clinical Cancer Research 2004 10 5 1706 1716
6. Miller K., Wang M., Gralow J., Dickler M., Cobleigh M., Perez E. A., Shenkier T., Cella D., Davidson N. E., Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer The New England Journal of Medicine 2007 357 26 2666 2676
7. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F., Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer The New England Journal of Medicine 2004 350 23 2335 2342
8. Roland C. L., Dineen S. P., Lynn K. D., Sullivan L. A., Dellinger M. T., Sadegh L., Sullivan J. P., Shames D. S., Brekken R. A., Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts Molecular Cancer Therapeutics 2009 8 7 1761 1771
9. Wilhelm S. M., Adnane L., Newell P., Villanueva A., Llovet J. M., Lynch M., Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Molecular Cancer Therapeutics 2008 7 10 3129 3140
10. Lacouture M. E., Wu S., Robert C., Atkins M. B., Kong H. H., Guitart J., Garbe C., Hauschild A., Puzanov I., Alexandrescu D. T., Anderson R. T., Wood L., Dutcher J. P., Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib Oncologist 2008 13 9 1001 1011
11. Dineen S. P., Lynn K. D., Holloway S. E., Miller A. F., Sullivan J. P., Shames D. S., Beck A. W., Barnett C. C., Fleming J. B., Brekken R. A., Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice Cancer Research 2008 68 11 4340 4346
12. Holloway S. E., Beck A. W., Shivakumar L., Shih J., Fleming J. B., Brekken R. A., Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts Annals of Surgical Oncology 2006 13 8 1145 1155
13. Korpanty G., Carbon J. G., Grayburn P. A., Fleming J. B., Brekken R. A., Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clinical Cancer Research 2007 13 1 323 330
14. Whitehurst B., Flister M. J., Bagaitkar J., Volk L., Bivens C. M., Pickett B., Castro-Rivera E., Brekken R. A., Gerard R. D., Ran S., Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model International Journal of Cancer 2007 121 10 2181 2191
15. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation Nature 2008 454 7203 436 444
16. Dineen S. P., Lynn K. D., Holloway S. E., Miller A. F., Sullivan J. P., Shames D. S., Beck A. W., Barnett C. C., Fleming J. B., Brekken R. A., Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice Cancer Research 2008 68 11 4340 4346
17. Zhang W., Ran S., Sambade M., Huang X., Thorpe P. E., A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model Angiogenesis 2002 5 1-2 35 44
18. Salnikov A. V., Heldin N.-E., Stuhr L. B., Wiig H., Gerber H., Reed R. K., Rubin K., Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinoma International Journal of Cancer 2006 119 12 2795 2802
19. De Visser K. E., Eichten A., Coussens L. M., Paradoxical roles of the immune system during cancer development Nature Reviews Cancer 2006 6 1 24 37
20. Oka N., Soeda A., Inagaki A., Onodera M., Maruyama H., Hara A., Kunisada T., Mori H., Iwama T., VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells Biochemical and Biophysical Research Communications 2007 360 3 553 559
21. Takahashi Y., Yamaoka K., Nishikawa M., Takakura Y., Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors Journal of Pharmaceutical Sciences 2009 98 1 74 80
22. Ma J. P., Yang Y., Zhang N., Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP Journal of Experimental Clinical Cancer Research 2010 29, article 56
23. Presta L. G., Chen H., O'Connor S. J., Chisholm V., Meng Y. G., Krummen L., Winkler M., Ferrara N., Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders Cancer Research 1997 57 20 4593 4599
24. Templeton N. S., Lasic D. D., Frederik P. M., Strey H. H., Roberts D. D., Pavlakis G. N., Improved DNA: liposome complexes for increased systemic delivery and gene expression Nature Biotechnology 1997 15 7 647 652
25. Tran J., Rak J., Sheehan C., Saibil S. D., Lacasse E., Korneluk R. G., Kerbel R. S., Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells Biochemical and Biophysical Research Communications 1999 264 3 781 788